CD274 and diffuse large B-cell lymphoma: The latest research has confirmed that in DLBCL, EBV-miRNA-BHRF1-2-5p targets LMP1 to drive the expression of PD-L1 and PD-L2, exerting context-dependent immune counter-regulation, leading to immune escape and contributing to persistent viral infection (98).